Capital Solutions For Healthcare Real Estate
Macallan Capital Partners provides comprehensive investment banking and advisory services for healthcare projects. Our team brings decades of experience in structuring capital solutions tailored to the unique requirements of this asset class.
Whether you are seeking debt financing, equity partnerships, or strategic advisory, we leverage our deep industry relationships and market expertise to deliver optimal outcomes for our clients.
Healthcare real estate represents the most essential and defensive segment of commercial property investment. Driven by demographic tailwindsâaging Baby Boomers, rising chronic disease prevalence, and increased demand for specialized care settingsâthe healthcare property market is projected to grow faster than overall CRE for decades. Medical office buildings, senior housing, and specialty facilities generate stable, inflation-protected cash flows from long-term relationships with essential service providers. The mission-critical nature of these assets, combined with limited new supply in certain submarkets, has attracted record capital from institutional investors seeking stable returns with downside protection.
Macallan Capital Partners leverages deep relationships with institutional capital sources specializing in healthcare real estate, including REITs, life insurance companies, healthcare-focused funds, and credit platforms. Our team brings comprehensive expertise across all healthcare property typesâfrom Class A medical office towers serving tertiary care networks to senior living communities with resident-level demographic certifications. We understand the complex interplay between tenant creditworthiness, operator quality, payor mix, and regulatory environments that define healthcare real estate value.
Class A and Class B facilities serving primary care physicians, specialists, and surgical centers. Strong tenant diversity with healthcare system anchors provides credit quality and rent growth with inflation protection.
Independent living, assisted living, and memory care communities serving affluent seniors. Experienced operators with strong resident satisfaction create repeat occupancy demand and outpace market growth.
Specialized laboratory facilities, R&D campuses, and GMP-compliant manufacturing spaces. Mission-critical tenant relationships with pharmaceutical and biotechnology leaders provide long-term lease stability and premium economic terms.
Post-acute care facilities and behavioral health centers providing essential services with government and private pay revenue streams. Operators with strong relationships and quality ratings benefit from regulatory moats and recurring demand.
Healthcare real estate transactions typically range from $30 million to $750 million depending on property type and sponsor profile. MOB portfolios and senior living communities tend toward the higher end, while individual assets and emerging sponsor platforms span the full range. Macallan structures transactions with particular attention to operator viability, payor mix composition, and compliance with regulatory frameworks that significantly impact long-term asset performance.
Beyond standard real estate underwriting, our team evaluates operator quality, management depth, and payor mix composition. We engage healthcare-specialized advisors to assess tenant credit within clinical and regulatory contexts, ensuring accurate assessment of long-term cash flow stability and re-tenanting risk.
Macallan maintains trusted relationships with healthcare REITs, healthcare-specialized credit funds, life insurance companies, and pension funds with dedicated healthcare allocation mandates. We leverage this network to source competitive term sheets and navigate the unique documentation requirements that healthcare lenders require.
We structure deals with explicit attention to healthcare regulatory frameworksâfrom fraud and abuse considerations in related-party transactions to licensing and compliance risks specific to senior living and behavioral health properties. Our guidance ensures transactions withstand regulatory scrutiny and maintain investor confidence throughout the hold period.